Kiran Mazumdar-Shaw is the head of Biocon, a company headquartered in Bengaluru and which has repurposed a drug […]
Tag: Itolizumab
If you’re looking for a quantification (although you shouldn’t) of the extent to which science is being conducted […]
Apparently (and surprisingly) The Telegraph didn’t allow Dinesh Thakur to respond to an article by Biocon employee Sundar Ramanan, in which […]